Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape.
Barnase
EpCAM
HER2
cancer therapy
liposomes
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
16 Oct 2020
16 Oct 2020
Historique:
received:
10
09
2020
revised:
06
10
2020
accepted:
13
10
2020
entrez:
21
10
2020
pubmed:
22
10
2020
medline:
22
10
2020
Statut:
epublish
Résumé
We report here a combined anti-cancer therapy directed toward HER2 and EpCAM, common tumor-associated antigens of breast cancer cells. The combined therapeutic effect is achieved owing to two highly toxic proteins-a low immunogenic variant of
Identifiants
pubmed: 33081407
pii: cancers12103014
doi: 10.3390/cancers12103014
pmc: PMC7602955
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Russian Science Support Foundation
ID : 19-14-00112
Organisme : Russian Science Support Foundation
ID : 20-14-18010
Références
Gynecol Oncol. 2006 Nov;103(2):483-8
pubmed: 16678891
Structure. 2013 Nov 5;21(11):1979-91
pubmed: 24095059
Prep Biochem. 1972;2(3):229-42
pubmed: 5031049
Eur J Cancer. 2018 Nov;104:1-8
pubmed: 30278378
Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11782-7
pubmed: 22753489
Curr Opin Biotechnol. 2011 Dec;22(6):843-8
pubmed: 21726995
Toxins (Basel). 2019 Oct 12;11(10):
pubmed: 31614771
Semin Oncol. 2014 Oct;41(5):653-60
pubmed: 25440609
J Mol Med (Berl). 1999 Oct;77(10):699-712
pubmed: 10606205
Breast Cancer Res Treat. 2019 Nov;178(2):263-274
pubmed: 31388935
Biochemistry. 1963 Jul-Aug;2:787-93
pubmed: 14075115
Cell. 2012 Mar 16;148(6):1081-4
pubmed: 22424219
J Photochem Photobiol B. 2018 Nov;188:107-115
pubmed: 30253374
Carcinogenesis. 2010 Nov;31(11):1913-21
pubmed: 20837599
Br J Cancer. 2007 Feb 12;96(3):417-23
pubmed: 17211480
Int J Mol Sci. 2019 May 15;20(10):
pubmed: 31096563
Eur J Pharm Biopharm. 2018 Sep;130:296-305
pubmed: 29959035
PLoS One. 2012;7(6):e39626
pubmed: 22737248
J Control Release. 2015 Feb 28;200:13-22
pubmed: 25526701
J Control Release. 2016 Jul 10;233:48-56
pubmed: 27178808
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Methods. 2004 Oct;34(2):184-99
pubmed: 15312672
Mol Biol (Mosk). 2017 Nov-Dec;51(6):997-1007
pubmed: 29271963
Onco Targets Ther. 2018 Nov 29;11:8455-8463
pubmed: 30555238
Clin Cancer Res. 2019 Sep 1;25(17):5202-5211
pubmed: 31142504
Methods Mol Biol. 2014;1091:17-32
pubmed: 24203322
Int J Cancer. 2002 Apr 20;98(6):883-8
pubmed: 11948467
ACS Nano. 2020 Oct 27;14(10):12781-12795
pubmed: 32935975
Annu Rev Pharmacol Toxicol. 2015;55:489-511
pubmed: 25562645
Hum Pathol. 2004 Jan;35(1):122-8
pubmed: 14745734
Methods Enzymol. 2012;503:101-34
pubmed: 22230567
Drugs. 2006;66(4):449-75
pubmed: 16597163
Lancet. 2000 Dec 9;356(9246):1981-2
pubmed: 11130529
PLoS One. 2012;7(10):e47995
pubmed: 23118918
PLoS One. 2008 Jun 18;3(6):e2434
pubmed: 18560598
J Mol Biol. 2011 Nov 4;413(4):826-43
pubmed: 21963989
Invest New Drugs. 2011 Feb;29(1):22-32
pubmed: 19789841
Cells. 2019 Jul 05;8(7):
pubmed: 31284534
Nat Cell Biol. 2009 Feb;11(2):162-71
pubmed: 19136966
Biochimie. 2015 Nov;118:116-22
pubmed: 26319592
Cancer Res. 2001 May 15;61(10):4105-11
pubmed: 11358833
Clin Cancer Res. 2011 Jan 1;17(1):100-10
pubmed: 21075824
MAbs. 2012 Mar-Apr;4(2):182-97
pubmed: 22453100
Nat Rev Drug Discov. 2006 Feb;5(2):147-59
pubmed: 16424916
Trends Biochem Sci. 1989 Nov;14(11):450-4
pubmed: 2696173
Nat Biotechnol. 2004 May;22(5):575-82
pubmed: 15097997
Cancer Res. 1999 Nov 15;59(22):5758-67
pubmed: 10582696
J Mol Biol. 2008 Oct 24;382(5):1211-27
pubmed: 18706916
MAbs. 2017 Feb/Mar;9(2):182-212
pubmed: 28071970